PRESS RELEASE published on 11/28/2025 at 13:10, 11 months 23 days ago Xlife Sciences AG Provides Update on VERAXA Biotech AG’s NASDAQ Listing Process Following U.S. Government Shutdown Xlife Sciences AG updates on VERAXA Biotech AG's NASDAQ listing process post U.S. Government Shutdown, SEC responds to Form F-4 filing, progress towards business combination with Voyager Acquisition Corp Nasdaq SEC Xlife Sciences AG VERAXA Biotech AG Voyager Acquisition Corp.
BRIEF published on 10/16/2025 at 07:05, 1 year 1 month ago Xlife Sciences AG publie son rapport ESG 2024 mettant en avant la croissance durable Croissance Durable Responsabilité Sociale Impact Environnemental Xlife Sciences Rapport ESG 2024
BRIEF published on 10/16/2025 at 07:05, 1 year 1 month ago Xlife Sciences AG Releases 2024 ESG Report Highlighting Sustainable Growth Environmental Impact Social Responsibility Sustainable Growth Xlife Sciences ESG Report 2024
PRESS RELEASE published on 10/16/2025 at 07:00, 1 year 1 month ago Xlife Sciences AG Publishes 2024 ESG Report: Sustainable Value Creation as a Strategic Core Xlife Sciences AG publishes 2024 ESG Report showcasing sustainable value creation through integrating ESG principles into corporate strategy and portfolio management in life sciences sector Life Sciences Xlife Sciences AG ESG Principles Sustainable Value Creation 2024 ESG Report
BRIEF published on 09/23/2025 at 07:05, 1 year 1 month ago Xlife Sciences AG Focuses on VERAXA's NASDAQ Listing in H1 2025 Financial Performance Nasdaq Listing Global Partnerships Xlife Sciences Biotech Expansion
BRIEF published on 09/23/2025 at 07:05, 1 year 1 month ago Xlife Sciences AG se concentre sur l'introduction de VERAXA au NASDAQ au premier semestre 2025 Performance Financière Partenariats Mondiaux Xlife Sciences Cotation Au Nasdaq Expansion Biotechnologique
PRESS RELEASE published on 09/23/2025 at 07:00, 1 year 1 month ago Xlife Sciences AG Half-Year Report 2025: Focus on VERAXA Biotech AG’s NASDAQ Listing and Internationalization Xlife Sciences AG released its Half-Year Report 2025 with focus on VERAXA Biotech AG's NASDAQ listing and internationalization. Operational and financial highlights were shared along with clear priorities for H2 2025 Nasdaq Listing Xlife Sciences AG Internationalization VERAXA Biotech AG Half-Year Report 2025
BRIEF published on 07/17/2025 at 07:05, 1 year 4 months ago VERAXA Biotech AG progresse vers la cotation au NASDAQ grâce au dépôt du formulaire F-4 Cotation Au Nasdaq VERAXA Biotech Regroupement D'entreprises Dépôt Du Formulaire F-4 Thérapeutiques Oncologiques
BRIEF published on 07/17/2025 at 07:05, 1 year 4 months ago VERAXA Biotech AG Advances Toward NASDAQ Listing with Form F-4 Filing Nasdaq Listing Business Combination Oncology Therapeutics VERAXA Biotech Form F-4 Filing
PRESS RELEASE published on 07/17/2025 at 07:00, 1 year 4 months ago Xlife Sciences AG’s Portfolio Company, VERAXA Biotech AG, Takes Key Step Toward NASDAQ Listing with Filing of Form F-4 Xlife Sciences AG's portfolio company VERAXA Biotech AG takes a key step towards NASDAQ listing with the filing of Form F-4, signaling continued momentum and billion-dollar valuation in the public market journey Nasdaq Listing Business Combination Xlife Sciences AG VERAXA Biotech AG Form F-4
Published on 11/20/2026 at 15:00, 1 day 19 hours ago Jaguar Health, Inc. Announces Reverse Stock Split
Published on 11/20/2026 at 14:50, 1 day 19 hours ago Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture
Published on 11/20/2026 at 14:00, 1 day 20 hours ago Dateline appoints Tony Ferguson as Acting Chairman
Published on 11/20/2026 at 13:30, 1 day 20 hours ago Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
Published on 11/20/2026 at 13:30, 1 day 20 hours ago Alset AI Closes Non-Brokered Private Placement Offering
Published on 11/20/2026 at 23:45, 1 day 10 hours ago APEC CEO Summit 2026 Concludes Successfully in Shenzhen
Published on 11/20/2026 at 22:39, 1 day 11 hours ago ABIVAX: Abivax publie une déclaration concernant le rapport d'un vendeur à découvert
Published on 11/20/2026 at 21:36, 1 day 12 hours ago EQS-Adhoc: Global Health Care AG: Board of Directors proposes sale of milon stake based on an equity value of EUR 23.3 million – subscription right for all shareholders
Published on 11/20/2026 at 20:49, 1 day 13 hours ago E-PANGO: Jugement du Tribunal Judiciaire de Paris relatif au contentieux avec le groupement RIVP-HENEO-HSF
Published on 11/20/2026 at 18:34, 1 day 15 hours ago Déclaration hebdomadaire d'opérations effectuées du 16 au 20 novembre 2026
Published on 11/20/2026 at 18:34, 1 day 15 hours ago Disclosure of transactions in own shares from November 16 to November 20, 2026
Published on 11/20/2026 at 17:35, 1 day 16 hours ago Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 16 au 20 novembre 2026
Published on 11/20/2026 at 17:35, 1 day 16 hours ago Guillemot Corporation S.A. | Weekly report share buyback from November 16 to November 20, 2026
Published on 11/19/2026 at 19:00, 2 days 15 hours ago MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR